GordonMD Global Investments LP

13D and 13G Filings

Issuer % of Class Filed
Schedule 13G · 2 securities · passive
Kyverna Therapeutics, Inc. 13G/A
KYTX · 501976104
7.3% 11/16/2026
Event 9/30/2026
Pyxis Oncology, Inc. 13G/A
PYXS · 747324101
16.4% 10/9/2026
Event 10/1/2026

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.